Tsveta Milanova is an accomplished Senior Executive and Thought Leader with over 17 years of experience in US, European and International Health Care Systems and biopharma market. She brings expertise in business and commercial strategy, marketing, launch & new product planning, policy shaping, pricing & access, health economics & outcomes research, and drug development. Her educational qualifications include a Management Development Program from the University of Virginia Darden School of Business, Master's degree in International Health policy from The London School of Economics and Political Science (LSE), and Executive Education from Harvard Business School, among others. Before joining Alexion Pharmaceuticals, she had worked in leadership roles at Celgene, GlaxoSmithKline, and Eli Lilly.